Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2016-10-28

Clinical Trial Update: Effects of Levothyroxine Treatment on Hemodynamic and Renal Functions in Subclinical Hypothyroidism [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating levothyroxine effects on hemodynamic and renal function in subclinical hypothyroidism has been withdrawn. No results will be…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Levothyroxine (levothyroxine)

Snippet

Sponsor: Centre Hospitalier Universitaire de Nice | Conditions: Subclinical hypothyroïdism | Phase 4 | Status: WITHDRAWN